Neurotrope Nears Breakthrough In New Alzheimer's Treatment Apr. 3, 2017 4:46 PM ET About: Neurotrope, Inc. (NTRP) by: Sharon di Stefano Sharon di Stefano Biotech, healthcare, small-cap, special situations (1,144 followers) Summary An extraordinary way to treat Alzheimer’s reaches Phase II. Top line data expected in April 2017 in placebo controlled study of bryostatin-1 in 148 moderate to severe Alzheimer's patients. Healing underlying causes versus symptoms can transform Alzheimer’s medicine. Lead drug bryostatin, from a natural source, can be synthesized for manufacturing efficiency. Common risks are translation of early results to larger trials, and competition. Full article: https://seekingalpha.com/article/4059932-neurotrope-nears-breakthrough-new-alzheimers-treatment?auth_param=v6t5:1ce5bcr | More Recs: 1 Views: 20